EUROFINS BIOPHARMA PRODUCT TESTING BIOLOGICS

What EUROFINS BIOPHARMA PRODUCT TESTING BIOLOGICS does

Eurofins BioPharma Product Testing Biologics is a service division within Eurofins Group (Euronext Paris: ERF), providing GMP-compliant laboratory testing services for biologic drug development, manufacturing, and commercial release. The division is part of Eurofins' broader BioPharma services portfolio, which also encompasses medical device testing, Contract Development & Manufacturing Organisation (CDMO) capabilities, PSS Insourcing Solutions® for on-site laboratory staffing, bioanalysis, Phase I clinical trial support, central biopharmaceutical laboratories, and biopharmaceutical discovery services. Eurofins Group was founded in 1987 and listed on Euronext Paris in 1997; the group is headquartered in Luxembourg and reports EUR 7.296 billion in revenue for fiscal year 2025.

The division operates through Eurofins' global network of more than 950 independent laboratories across 59 countries, deploying more than 200,000 analytical methods and conducting more than 450 million tests annually. Within BioPharma, Eurofins supports testing across the full drug development lifecycle — from discovery and early-phase clinical trials through commercial product release testing — leveraging regulatory accreditation, laboratory proximity to clients, and embedded insourcing solutions that place Eurofins personnel directly within client facilities. Specialized offerings include PFAS detection and quantification, microplastics analysis, and broader environmental, agrosciences, genomics, forensic, and clinical diagnostic testing capabilities.

Eurofins Biopharma Product Testing Biologics generates revenue through contract testing arrangements with pharmaceutical, biotech, and medical device companies, executed under a direct enterprise field-sales go-to-market model. Customers identify their nearest laboratory through the Eurofins website's locator tool and engage directly with Eurofins scientists for testing projects; pricing is not publicly disclosed and is established bilaterally through commercial engagement. The division sits within a publicly listed parent with a diversified horizontal customer base spanning pharma, biotech, medical device, diagnostics, food/environmental, and forensic end markets.

Name

EUROFINS BIOPHARMA PRODUCT TESTING BIOLOGICS

Legal name

Eurofins

Website

https://eurofins.fr

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Eurofins BioPharma Product Testing Biologics is a division of Eurofins Group providing GMP-compliant laboratory testing for biologic drug development, manufacturing, and release. It operates within a global network of 950+ laboratories across 59 countries serving pharmaceutical, biotech, and medical device clients.

Ownership category

akta.pro rank

Product category

BioPharmaceutical Testing Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

akta.pro secondary industries

Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), Release Testing & Batch Certification (QC) (HLAGADAC), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Biopharmaceutical product testing
• Medical device testing
• Contract development manufacturing
• Bioanalytical services
• Central laboratory services

Headquarters

HQ city

Lentilly

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. BioPharma Product Testing Services: Eurofins generates revenue through a comprehensive suite of biopharma services including product testing, medical device services, CDMO, bioanalysis, central laboratories, and drug discovery services, as well as PSS Insourcing Solutions embedded within client sites. Revenue is generated through contract testing arrangements with pharmaceutical and biotech companies globally.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Eurofins BioPharma Product Testing Biologics provides GMP-compliant laboratory testing services for biologic drug development and manufacturing. Its offerings span biopharmaceutical product testing, medical device services, contract development and manufacturing (CDMO), PSS Insourcing Solutions® that embed scientists inside client sites, bioanalysis and Phase I clinical trial support, biopharmaceutical discovery services, and centralized biopharma laboratory services delivered across a global network of 950+ independent laboratories.

Product overview

Eurofins operates as a network of independent laboratories providing comprehensive testing and analysis services across multiple sectors. Within BioPharma, the company offers biopharmaceutical product testing services, medical device services, Contract Development & Manufacturing Organisation (CDMO) services, PSS Insourcing Solutions® for on-site laboratory staffing, bioanalysis and Phase I clinical trial support, biopharmaceutical discovery services, and central biopharmaceutical laboratories. The broader portfolio extends to agrosciences, genomics, forensic services, in vitro diagnostics solutions, medical biology, and specialized environmental testing for PFAS and microplastics. The company operates more than 950 laboratories across 59 countries with over 65,000 employees.

Differentiator

Problem solved

Functional benefit

Brands

• BioPharma Services: Comprehensive biopharmaceutical services including product testing, bioanalysis, clinical trials, and discovery services
• PSS Insourcing Solutions®
• CDMO
• Agrosciences
• Genomics

Products and services

• Biopharmaceutical Product Testing (Tests de produits biopharmaceutiques) Comprehensive analytical testing, quality control, and regulatory compliance support services for biopharmaceutical products, delivered to pharmaceutical and biotech customers.
• Medical Device Services (Services pour dispositifs médicaux) Testing and regulatory services for medical devices, supporting safety, performance, and compliance with applicable standards for medical device manufacturers.
• Contract Development & Manufacturing Organisation (CDMO) Contract development and manufacturing services for biopharmaceutical products, including drug substance and drug product development, for biopharma sponsors.
• PSS Insourcing Solutions® On-site insourcing solution that places dedicated Eurofins laboratory personnel and expertise inside client facilities, reducing the client's operational burden.
• Bioanalysis and Phase I Clinical Trials (Bioanalyse et essais cliniques de phase I) Bioanalytical services supporting Phase I clinical trials, covering method development, validation, and sample analysis for biopharmaceutical development programs.
• Biopharmaceutical Discovery Services and Products (Services et produits de découverte biopharmaceutique) Discovery services and products supporting early-stage biopharmaceutical research and development for biopharma clients.
• Central Biopharmaceutical Laboratories (Laboratoires centraux de biopharmaceutique) Centralized laboratory facilities providing standardized testing services for biopharmaceutical products across the global Eurofins network, supporting clinical trials and product testing programs.
• Agrosciences Services Agricultural sciences testing services, including crop protection, seed testing, and agricultural product analysis for agroscience customers.
• Genomics Services (Génomique) Genomic testing and analysis services, including DNA sequencing, genetic testing, and molecular diagnostics for clients across healthcare and research.
• Forensic Services (Services médico-légaux) Forensic science services covering toxicology, DNA analysis, and investigative analytical support for legal and law enforcement clients.
• In Vitro Diagnostics Solutions (Solutions de diagnostic in vitro) In vitro diagnostic testing solutions, including reagent development, assay validation, and diagnostic product testing for diagnostic manufacturers and clinical labs.
• Medical Biology and Anatomo-Cytopathology (Biologie Médicale et Anatomo-Cytopathologie) Medical biology and anatomical pathology services supporting clinical diagnostics and disease diagnosis for healthcare providers and patients.
• PFAS Testing Services Detection and quantification of per- and polyfluoroalkyl substances (PFAS) across environmental and consumer product matrices for regulatory and analytical needs.
• Microplastics Detection Services Detection and quantification of microplastics to support environmental protection and product safety assessment for commercial clients.

Quantifiable outcome

• 450+ million tests conducted per year
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SGS: Global testing, inspection, and certification company with a life sciences division offering biopharma testing services. Comparable as a broad-based analytical testing network serving pharma, food, and environmental end markets.
• Bureau Veritas: International testing, inspection, and certification company with a life sciences and agri-food vertical. Comparable as a network-based testing services competitor serving regulated industries including pharmaceuticals and consumer products.
• WuXi AppTec: Global CRO/CDMO offering laboratory testing, bioanalytical services, and biologics manufacturing support. Overlaps with Eurofins Biopharma Product Testing in biologics testing, release testing, and central laboratory services for pharma clients.
• Intertek: Global testing and quality assurance provider with pharmaceutical and biopharma testing services. Comparable in offering analytical testing across pharma, food, and consumer product segments under a multi-country laboratory network.
• Charles River Laboratories: A leading CRO providing non-clinical and biopharma product testing, bioanalysis, and manufacturing services to pharma and biotech clients. Directly comparable as a scientific services partner across the biopharma development lifecycle, with overlapping offerings in release testing, bioanalysis, and biologics support.
• Catalent: Global CDMO with biopharmaceutical development, manufacturing, and analytical services. Comparable in providing integrated testing and development/manufacturing services for biologics, with similar pharma/biotech customer base.
• Labcorp (incl. Covance / Fortrea): Global diagnostics and biopharma laboratory services company with deep bioanalytical, central lab, and clinical trial testing capabilities. Highly comparable in serving pharma/biotech customers across drug development with laboratory testing at scale.
• IQVIA: Major clinical research and biopharma services provider with central laboratory operations and bioanalytical capabilities. Competes directly for outsourced testing and laboratory services tied to clinical trials and commercial biopharma products.

Emerging players

• Bio-Techne: Life sciences tools and diagnostics company with proteomics and biomarker analytical reagents used in biopharma research and testing workflows. Tangentially comparable in serving biopharma laboratories with analytical tools and biomarker assay capabilities.

Broad incumbents

• Thermo Fisher Scientific (PPD): Diversified life sciences tools and biopharma services provider with clinical trial testing, central lab, and bioanalytical offerings through PPD. Overlaps with Eurofins in biopharma testing but operates as part of a much larger instrumentation and tools portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/EurofinsGlobal
• LinkedInlinkedin.com/company/eurofins
• Instagraminstagram.com/eurofinsglobal

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUROFINS BIOPHARMA PRODUCT TESTING BIOLOGICS